Autologous EBV specific CTL (Nantes University Hospital)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAutologous EBV specific CTL (Nantes University Hospital)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Cytotoxic T-lymphocytes therapy

Mechanisms of ActionUpdating

TargetsNot applicable

Therapy Area/IndicationsLupus Erythematosus, Systemic

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNantes University Hospital

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNantes University Hospital

Active IndicationsN/A

Inactive IndicationsLupus Erythematosus, Systemic

Other Information

ATC CodeN/A